SYMPTOMS OF PATIENTS WITH DIFFUSE GLIOMA DURING STABLE DISEASE AS A POTENTIAL TARGET FOR TREATMENT

被引:0
|
作者
Rottgering, J. G. [1 ,2 ]
Belgers, V. [1 ,3 ]
Kouwenhoven, M. C. M. [1 ,3 ]
Schuur, M. [1 ,3 ]
Postma, T. J. [1 ,3 ]
Nijboer, C. M. [1 ,3 ]
van Linde, M. E. [1 ,4 ]
Hamer, P. de Witt [1 ,5 ]
Douw, L. [1 ,6 ]
Klein, M. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam UMC, Dept Med Psychol, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam UMC, Dept Neurol, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam UMC, Dept Oncol, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Amsterdam UMC, Dept Neurosurg, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Neurosci, Dept Anat & Neurosci, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P12.02
引用
收藏
页码:30 / 31
页数:2
相关论文
共 50 条
  • [1] Cognitive functioning of patients with diffuse glioma during stable disease
    Gorter, M.
    Rottgering, J. G.
    Belgers, V
    van Lingen, M. R.
    Hamer, P. C. De Witt
    Douw, L.
    Klein, M.
    NEURO-ONCOLOGY, 2022, 24
  • [2] Frequency and burden of potentially treatable symptoms in glioma patients with stable disease
    Rottgering, Jantine G.
    Belgers, Vera
    Kouwenhoven, Mathilde C. M.
    Schuur, Maaike
    Postma, Tjeerd J.
    Nijboer, Claudia M.
    van Linde, Myra E.
    Hamer, Philip C. de Witt
    Douw, Linda
    Klein, Martin
    HELIYON, 2023, 9 (02)
  • [3] MELK INHIBITION AS A POTENTIAL TREATMENT FOR DIFFUSE INTRINSIC PONTINE GLIOMA
    Meel, Michael H.
    de Gooijer, Mark C.
    Waranecki, Piotr
    van Tellingen, Olaf
    Kaspers, Gertjan J. L.
    Hulleman, Esther
    NEURO-ONCOLOGY, 2016, 18 : 59 - 59
  • [4] BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma
    Kumar, Shiva Senthil
    Sengupta, Satarupa
    Lee, Kyungwoo
    Hura, Nanki
    Fuller, Christine
    DeWire, Mariko
    Stevenson, Charles B.
    Fouladi, Maryam
    Drissi, Rachid
    ONCOTARGET, 2017, 8 (38) : 62962 - 62975
  • [5] DEPRESSIVE SYMPTOMS IN ASSOCIATION WITH TUMOR LOCATIONS AT DIAGNOSIS IN PATIENTS WITH DIFFUSE GLIOMA
    van Genderen, M. N. G.
    Belgers, V.
    Douw, L.
    Barkhof, F.
    Klein, M.
    Niers, J. M.
    Eijgelaar, R. S.
    Hamer, P. C. de Witt
    NEURO-ONCOLOGY, 2023, 25
  • [6] Aurora Kinase B Is a Potential Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma
    Buczkowicz, Pawel
    Zarghooni, Maryam
    Bartels, Ute
    Morrison, Andrew
    Misuraca, Katherine L.
    Chan, Tiffany
    Bouffet, Eric
    Huang, Annie
    Becher, Oren
    Hawkins, Cynthia
    BRAIN PATHOLOGY, 2013, 23 (03) : 244 - 253
  • [7] REPEATED TREATMENT-ASSOCIATED CHANGES IN PATIENTS WITH A DIFFUSE GLIOMA
    Mechroubi, A.
    Flies, C. M.
    Dankbaar, J. W.
    Verhoeff, J. J. C.
    Robe, P. A.
    Snijders, T. J.
    NEURO-ONCOLOGY, 2024, 26
  • [8] Incidence and Kinetics of Neurologic Symptoms During Radiation Therapy for Diffuse Intrinsic Pontine Glioma
    Campbell, K.
    Li, Y.
    Merchant, T. E.
    Broniscer, A.
    Tinkle, C. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E565 - E565
  • [9] TMIGD2 as a potential therapeutic target in glioma patients
    Boulhen, Chaimae
    Ssi, Saadia Ait
    Benthami, Hamza
    Razzouki, Ibtissam
    Lakhdar, Abdelhakim
    Karkouri, Mehdi
    Badou, Abdallah
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma
    Amani, Vladimir
    Prince, Eric W.
    Alimova, Irina
    Balakrishnan, Ilango
    Birks, Diane
    Donson, Andrew M.
    Harris, Peter
    Levy, Jean M. Mulcahy
    Handler, Michael
    Foreman, Nicholas K.
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    BMC CANCER, 2016, 16